Publications

Publications:

  1. Strowd RE, Kim AH. Meeting update-Society for Neuro-Oncology 2016 annual meeting. Neuro Oncol. 2017 Feb 1;19(2):150-152. PubMed PMID: 28391300.
  2. Rao YJ, Hassanzadeh C, Fischer-Valuck B, Chicoine MR, Kim AH, et al. Patterns of care and treatment outcomes of patients with craniopharyngioma in the national cancer database. J Neurooncol. 2017 Mar;132(1):109-117. PubMed PMID: 28012064.
  3. Kang P, Bucelli RC, Ferguson CJ, Corbo JC, Kim AH, Day GS. Teaching NeuroImages: Cerebral amyloid angiopathy-related inflammation presenting with isolated leptomeningitis. Neurology. 2017 Aug 8;89(6):e66-e67. PubMed PMID: 28784645.
  4. Das S, Kim AH, Chang S, Berger MS. Management of Elderly Patients with Glioblastoma after CE.6.Front Oncol. 2017 Aug 30;7:196. PMID: 28913179. PMCID: PMC5582080.
  5. Kamath AA, Friedman DD, Hacker CD, Smyth MD, Limbrick DD Jr, Kim AH, Hawasli AH, Leuthardt EC. MRI-Guided Interstitial Laser Ablation for Intracranial Lesions: A Large Single-Institution Experience of 133 Cases.Stereotact Funct Neurosurg. 2017;95(6):417-428. PMID: 29339639
  6. Strowd RE, Kim AH, Wen PY. Meeting Update-Society for Neuro-Oncology 2017 Annual Meeting.Neuro Oncol. 2018 Jan 22;20(2):156-159. PubMed PMID: 29365203; PubMed Central PMCID: PMC5777479.
  7. Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, Bando JK, Kim AH, Walker J, Andahazy M, Bugatti M, Melocchi L, Vermi W, Fremont DH, Cox S, Cella M, Schmedt C, Colonna M. Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell. 2018 Jan 25;172(3):534-548.e19. PubMed PMID: 29275861.
  8. Reynolds MR, Arias EJ, Derdeyn CP, Kim AH. Transorbital intracranial penetrating trauma with carotid artery injury: a multidisciplinary approach to management. J Neurosurg Sci. 2018 Feb;62(1):89-91. doi: 10.23736/S0390-5616.16.03643-2. PubMed PMID: 29239162.
  9. Beaumont TL, Mohammadi AM, Kim AH, Barnett GH, Leuthardt EC. Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Glioblastoma of the Corpus Callosum. Neurosurgery. 2018 Feb 8. doi: 10.1093/neuros/nyx518. [Epub ahead of print] PubMed PMID: 29438526.
  10. Mahlokozera T, Vellimana AK, Li T, Mao DD, Zohny ZS, Kim DH, Tran DD, Marcus DS, Fouke SJ, Campian JL, Dunn GP, Miller CA, Kim AH. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma. Neuro Oncol. 2018 Mar 27;20(4):472-483. doi: 10.1093/neuonc/nox232. PubMed PMID: 29244145; PubMed Central PMCID: PMC5909635.
  11. Huang J, Campian JL, Gujar AD, Tsien C, Ansstas G, Tran DD, DeWees TA, Lockhart AC, Kim AH. Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma. J Neurooncol. 2018 May;138(1):105-111. PubMed PMID: 29374809.
  12. Taiwo R, Mahlokozera T, Kim AH.Stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool.Stem Cell Investig. 2018 Jul 23;5:22.
  13. Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, Kim AH, Dunn GP, Robinson CG, Chicoine MR, Huang J, Abraham CD. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Radiother Oncol. 2018 Aug;128(2):266-273. 
  14. Kamath AA, Friedman DD, Akbari SHA, Kim AH, Tao Y, Luo J, Leuthardt EC. Glioblastoma Treated With Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy: Safety, Efficacy, and Outcomes.Neurosurgery. 2018 Aug 22. 
  15. Lin AJ, Hui C, Dahiya S, Lu HC, Kim AH, Campian JL, Tsien C, Zipfel GJ, Rich KM, Chicoine M, Huang J. Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):194-203. 
  16. A. Kim, S. Roffler-Tarlov, and C.S. Lin. New technique for precise alignment of an RNA differential display gel with its film image. Biotechniques, 1995. 19(3): p. 346.
  17. C. Ayata, G. Ayata, H. Hara, R.T. Matthews, M.F. Beal, R.J. Ferrante, M. Endres, A. Kim, R.H. Christie, C. Waeber, P.L. Huang, B.T. Hyman, and M.A. Moskowitz. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci, 1997. 17(18): p. 6908-17.
  18. H. Kong, A.H. Kim, J.R. Orlinick, and M.V. Chao. A comparison of the cytoplasmic domains of the Fas receptor and the p75 neurotrophin receptor. Cell Death Differ, 1999. 6(11): p. 1133-42.
  19. A.H. Kim, C.T. Sheline, M. Tian, T. Higashi, R.J. McMahon, R.J. Cousins, and D.W. Choi. L-type Ca(2+) channel-mediated Zn(2+) toxicity and modulation by ZnT-1 in PC12 cells. Brain Res, 2000. 886(1-2): p. 99-107.
  20. A.H. Kim, G. Khursigara, X. Sun, T.F. Franke, and M.V. Chao. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol, 2001. 21(3): p. 893-901.
  21. F.S. Lee, A.H. Kim, G. Khursigara, and M.V. Chao. The uniqueness of being a neurotrophin receptor. Curr Opin Neurobiol, 2001. 11(3): p. 281-6.
  22. S.P. Duntley, A.H. Kim, D.L. Silbergeld, and J.W. Miller. Characterization of the mu rhythm during rapid eye movement sleep. Clin Neurophysiol, 2001. 112(3): p. 528-31.
  23. A.H. Kim, H. Yano, H. Cho, D. Meyer, B. Monks, B. Margolis, M.J. Birnbaum, and M.V. Chao. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron, 2002. 35(4): p. 697-709.
  24. F.S. Lee, R. Rajagopal, A.H. Kim, P.C. Chang, and M.V. Chao. Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J Biol Chem, 2002. 277(11): p. 9096-102.
  25. A.H. Kim, T. Sasaki, and M.V. Chao. JNK-interacting protein 1 promotes Akt1 activation. J Biol Chem, 2003. 278(32): p. 29830-6.
  26. A.H. Kim, C.O. Maher, and E.R. Smith. Lumbar intramedullary spinal schistosomiasis presenting as progressive paraparesis: case report. Neurosurgery, 2006. 58(5): p. E996; discussion E996.
  27. A.H. Kim and A. Bonni. Thinking within the D box: initial identification of Cdh1-APC substrates in the nervous system. Mol Cell Neurosci, 2007. 34(3): p. 281-7.
  28. A.H. Kim and A. Bonni. Cdk1-FOXO1: a mitotic signal takes center stage in post-mitotic neurons. Cell Cycle, 2008. 7(24): p. 3819-22.
  29. J.K. Tailor, A.H. Kim, R.D. Folkerth, and P.M. Black. The development of ring-shaped contrast enhancement in a case of cerebellar dysembryoplastic neuroepithelial tumor: case report. Neurosurgery, 2008. 63(3): p. E609-10; discussion E610.
  30. A.H. Kim, S.V. Puram, P.M. Bilimoria, Y. Ikeuchi, S. Keough, M. Wong, D. Rowitch, and A. Bonni. A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell, 2009. 136(2): p. 322-36.
  31. A.H. Nagahara, D.A. Merrill, G. Coppola, S. Tsukada, B.E. Schroeder, G.M. Shaked, L. Wang, A. Blesch, A. Kim, J.M. Conner, E. Rockenstein, M.V. Chao, E.H. Koo, D. Geschwind, E. Masliah, A.A. Chiba, and M.H. Tuszynski. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med, 2009. 15(3): p. 331-7.
  32. Y. Yang, A.H. Kim, T. Yamada, B. Wu, P.M. Bilimoria, Y. Ikeuchi, N. de la Iglesia, J. Shen, and A. Bonni. A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science, 2009. 326(5952): p. 575-8.
  33. G. Zada, A.H. Kim, L.S. Governale, and E.R. Laws. Midline filum of the sellar dura: a useful landmark during endoscopic transsphenoidal pituitary surgery. Neurosurgery, 2010. 67(2 Suppl Operative): p. 391-4.
  34. Y. Yang, A.H. Kim, and A. Bonni. The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20-APC regulate neuronal morphogenesis and connectivity. Curr Opin Neurobiol, 2010. 20(1): p. 92-9.
  35. S.V. Puram, A.H. Kim, and A. Bonni. An old dog learns new tricks: a novel function for Cdc20-APC in dendrite morphogenesis in neurons. Cell Cycle, 2010. 9(3): p. 482-5.
  36. G.M. Shankar, L. Chen, A.H. Kim, G.L. Ross, R.D. Folkerth, and R.M. Friedlander. Composite ganglioneuroma-paraganglioma of the filum terminale. J Neurosurg Spine, 2010. 12(6): p. 709-13.
  37. S.V. Puram, A.H. Kim, Y. Ikeuchi, J.T. Wilson-Grady, A. Merdes, S.P. Gygi, and A. Bonni. A CaMKIIbeta signaling pathway at the centrosome regulates dendrite patterning in the brain. Nat Neurosci, 2011. 14(8): p. 973-83.
  38. S.V. Puram, A. Riccio, S. Koirala, Y. Ikeuchi, A.H. Kim, G. Corfas, and A. Bonni. A TRPC5-regulated calcium signaling pathway controls dendrite patterning in the mammalian brain. Genes Dev, 2011. 25(24): p. 2659-73.
  39. A.H. Kim, M.K. Kasliwal, B. McNeish, V.M. Silvera, M.R. Proctor, and E.R. Smith. Features of the lumbar spine on magnetic resonance images following sectioning of filum terminale. J Neurosurg Pediatr, 2011. 8(4): p. 384-9.
  40. A.H. Kim, L.S. Governale, D.H. Kim, and P.M. Black. The management of skull base tumors. Handb Clin Neurol, 2012. 105: p. 657-64.
  41. N. Lin, G. Zenonos, A.H. Kim, S.V. Nalbach, R. Du, K.U. Frerichs, R.M. Friedlander, and W.B. Gormley. Angiogram-negative subarachnoid hemorrhage: relationship between bleeding pattern and clinical outcome. Neurocrit Care, 2012. 16(3): p. 389-98.
  42. J.M. Wong, J.E. Ziewacz, A.L. Ho, J.R. Panchmatia, A.H. Kim, A.M. Bader, B.G. Thompson, R. Du, and A.A. Gawande. Patterns in neurosurgical adverse events: open cerebrovascular neurosurgery. Neurosurg Focus, 2012. 33(5): p. E15.
  43. S.V. Puram, A.H. Kim, H.Y. Park, J. Anckar, and A. Bonni. The ubiquitin receptor S5a/Rpn10 links centrosomal proteasomes with dendrite development in the mammalian brain. Cell Rep, 2013. 4(1): p. 19-30.
  44. M.D. Brooks, E. Jackson, N.M. Warrington, J. Luo, J.T. Forys, S. Taylor, D.D. Mao, J.R. Leonard, A.H. Kim, D. Piwnica-Worms, R.D. Mitra, and J.B. Rubin. PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells. PLoS One, 2014. 9(9): p. e107397.
  45. D.J. Aum, D.H. Kim, T.L. Beaumont, E.C. Leuthardt, G.P. Dunn, and A.H. Kim. Molecular and cellular heterogeneity: the hallmark of glioblastoma. Neurosurg Focus, 2014. 37(6): p. E11.
  46. A.H. Hawasli, A.H. Kim, G.P. Dunn, D.D. Tran, and E.C. Leuthardt. Stereotactic laser ablation of high-grade gliomas. Neurosurg Focus, 2014. 37(6): p. E1.
  47. S.J. Fouke, T.L. Benzinger, M. Milchenko, P. LaMontagne, J.S. Shimony, M.R. Chicoine, K.M. Rich, A.H. Kim, E.C. Leuthardt, B. Keogh, and D.S. Marcus. The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers. Neurosurgery, 2014. 74(1): p. 88-98.
  48. A.L. Lin, J. Liu, J. Evans, E.C. Leuthardt, K.M. Rich, R.G. Dacey, J.L. Dowling, A.H. Kim, G.J. Zipfel, R.L. Grubb, J. Huang, C.G. Robinson, J.R. Simpson, G.P. Linette, M.R. Chicoine, and D.D. Tran. Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol, 2014. 16(1): p. 123-30.
  49. H. Yano, S.V. Baranov, O.V. Baranova, J. Kim, Y. Pan, S. Yablonska, D.L. Carlisle, R.J. Ferrante, A.H. Kim, and R.M. Friedlander. Inhibition of mitochondrial protein import by mutant huntingtin. Nat Neurosci, 2014. 17(6): p. 822-31.
  50. S.N. Badiyan, S. Markovina, J.R. Simpson, C.G. Robinson, T. DeWees, D.D. Tran, G. Linette, R. Jalalizadeh, R. Dacey, K.M. Rich, M.R. Chicoine, J.L. Dowling, E.C. Leuthardt, G.J. Zipfel, A.H. Kim, and J. Huang. Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide. Int J Radiat Oncol Biol Phys, 2014. 90(4): p. 877-85.
  51. A.H. Kim, E.A. Thompson, L.S. Governale, C. Santa, K. Cahll, M.W. Kieran, S.N. Chi, N.J. Ullrich, R.M. Scott, and L.C. Goumnerova. Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imaging. J Neurosurg Pediatr, 2014. 14(4): p. 356-64.
  52. S.Q. Sun, C. Cai, R.K. Murphy, T. DeWees, R.G. Dacey, R.L. Grubb, K.M. Rich, G.J. Zipfel, J.L. Dowling, E.C. Leuthardt, J.R. Leonard, J. Evans, J.R. Simpson, C.G. Robinson, R.J. Perrin, J. Huang, M.R. Chicoine, and A.H. Kim. Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery, 2014. 75(4): p. 356-63; discussion 363.
  53. S.Q. Sun, A.H. Kim, C. Cai, R.K. Murphy, T. DeWees, P. Sylvester, R.G. Dacey, R.L. Grubb, K.M. Rich, G.J. Zipfel, J.L. Dowling, E.C. Leuthardt, J.R. Leonard, J. Evans, J.R. Simpson, C.G. Robinson, R.J. Perrin, J. Huang, and M.R. Chicoine. Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery, 2014. 75(4): p. 347-54; discussion 354-5; quiz 355.
  54. A.A. Garsa, S.N. Badiyan, T. DeWees, J.R. Simpson, J. Huang, R.E. Drzymala, I.J. Barani, J.L. Dowling, K.M. Rich, M.R. Chicoine, A.H. Kim, E.C. Leuthardt, and C.G. Robinson. Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases. Int J Radiat Oncol Biol Phys, 2014. 90(2): p. 407-13.
  55. C.C. Zygourakis, V. Vasudeva, P.M. Lai, A.H. Kim, H. Wang, and R. Du. Transient pupillary dilation following local papaverine application in intracranial aneurysm surgery. J Clin Neurosci, 2015. 22(4): p. 676-9.
  56. J. Huang, T.A. DeWees, S.N. Badiyan, C.K. Speirs, D.F. Mullen, S. Fergus, D.D. Tran, G. Linette, J.L. Campian, M.R. Chicoine, A.H. Kim, G. Dunn, J.R. Simpson, and C.G. Robinson. Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma. Int J Radiat Oncol Biol Phys, 2015. 92(5): p. 1000-7.
  57. P.T. Sylvester, J.A. Evans, G.J. Zipfel, R.A. Chole, R. Uppaluri, B.H. Haughey, A.E. Getz, J. Silverstein, K.M. Rich, A.H. Kim, R.G. Dacey, and M.R. Chicoine, Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas. Pituitary, 2015. 18(1): p. 72-85.
  58. C.K. Speirs, J.R. Simpson, C.G. Robinson, T.A. DeWees, D.D. Tran, G. Linette, M.R. Chicoine, R.G. Dacey, K.M. Rich, J.L. Dowling, E.C. Leuthardt, G.J. Zipfel, A.H. Kim, and J. Huang. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide. Int J Radiat Oncol Biol Phys, 2015. 91(2): p. 268-76.
  59. R. Sengupta, A. Barone, J. Marasa, S. Taylor, E. Jackson, N.M. Warrington, S. Rao, A.H. Kim, J.R. Leonard, D. Piwnica-Worms, and J.B. Rubin, Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions. Oncotarget, 2015. 6(21): p. 18282-92.
  60. S.Q. Sun, C. Cai, V.M. Ravindra, P. Gamble, C.K. Yarbrough, R.G. Dacey, J.L. Dowling, G.J. Zipfel, N.M. Wright, P. Santiago, C.G. Robinson, M.H. Schmidt, A.H. Kim, and W.Z. Ray, Simpson Grade I-III Resection of Spinal Atypical (World Health Organization Grade II) Meningiomas is Associated With Symptom Resolution and Low Recurrence. Neurosurgery, 2015. 76(6): p. 739-46.
  61. D.D. Mao, A.D. Gujar, T. Mahlokozera, I. Chen, Y. Pan, J. Luo, T. Brost, E.A. Thompson, A. Turski, E.C. Leuthardt, G.P. Dunn, M.R. Chicoine, K.M. Rich, J.L. Dowling, G.J. Zipfel, R.G. Dacey, S. Achilefu, D.D. Tran, H. Yano, and A.H. Kim. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells. Cell Rep, 2015. 11(11): p. 1809-21.
  62. S.Q. Sun, A.H. Hawasli, J. Huang, M.R. Chicoine, and A.H. Kim. An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas. Neurosurg Focus, 2015. 38(3): p. E3.
  63. S.Q. Sun, C. Cai, R.K. Murphy, T. DeWees, R.G. Dacey, R.L. Grubb, K.M. Rich, G.J. Zipfel, J.L. Dowling, E.C. Leuthardt, J.R. Simpson, C.G. Robinson, M.R. Chicoine, R.J. Perrin, J. Huang, and A.H. Kim. Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes. Neurosurgery, 2015.
  64. E.C. Leuthardt, C. Duan, M.J. Kim, J.L. Campian, A.H. Kim, M.M. Miller-Thomas, J.S. Shimony, and D.D. Tran. Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier. PLoS One, 2016. 11(2): p. e0148613.
  65. Y. Pan, T. Daito, Y. Sasaki, Y.H. Chung, X. Xing, S. Pondugula, S.J. Swamidass, T. Wang, A.H. Kim, and H. Yano. Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity. Sci Rep, 2016. 6: p. 31022.
  66. S.K. Kang, R.K. Murphy, S.W. Hwang, S.M. Lee, D.V. Harburg, N.A. Krueger, J. Shin, P. Gamble, H. Cheng, S. Yu, Z. Liu, J.G. McCall, M. Stephen, H. Ying, J. Kim, G. Park, R.C. Webb, C.H. Lee, S. Chung, D.S. Wie, A.D. Gujar, B. Vemulapalli, A.H. Kim, K.M. Lee, J. Cheng, Y. Huang, S.H. Lee, P.V. Braun, W.Z. Ray, and J.A. Rogers. Bioresorbable silicon electronic sensors for the brain. Nature, 2016. 530(7588): p. 71-6.
  67. D.Y. Dadey, V. Kapoor, A. Khudanyan, F. Urano, A.H. Kim, D. Thotala, and D.E. Hallahan. The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma. Oncotarget, 2016. 7(2): p. 2080-92.
  68. P.T. Sylvester, C.J. Moran, C.P. Derdeyn, D.T. Cross, R.G. Dacey, G.J. Zipfel, A.H. Kim, R. Uppaluri, B.H. Haughey, R. Tempelhoff, K.M. Rich, J. Schneider, R.A. Chole, and M.R. Chicoine. Endovascular management of internal carotid artery injuries secondary to endonasal surgery: case series and review of the literature. J Neurosurg, 2016: p. 1-21.
  69. S.Q. Sun, C. Cai, R.K. Murphy, T. DeWees, R.G. Dacey, R.L. Grubb, K.M. Rich, G.J. Zipfel, J.L. Dowling, E.C. Leuthardt, J.R. Simpson, C.G. Robinson, M.R. Chicoine, R.J. Perrin, J. Huang, and A.H. Kim. Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes. Neurosurgery, 2016. 79(1): p. 23-32.
  70. T.M. Johanns, Y. Fu, D.K. Kobayashi, Y. Mei, I.F. Dunn, D.D. Mao, A.H. Kim, and G.P. Dunn. High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathol, 2016.
  71. J. Huang, J.L. Campian, A.D. Gujar, D.D. Tran, A.C. Lockhart, T.A. DeWees, C.I. Tsien, and A.H. Kim. A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. J Neurooncol, 2016.
  72. A.D. Gujar, H. Yano, and A.H. Kim. The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma. Mol Cell Oncol, 2016. 3(3): p. e1075644.
  73. D.Y. Dadey, A.A. Kamath, M.D. Smyth, M.R. Chicoine, E.C. Leuthardt, and A.H. Kim. Utilizing personalized stereotactic frames for laser interstitial thermal ablation of posterior fossa and mesiotemporal brain lesions: a single-institution series. Neurosurg Focus, 2016. 41(4): p. E4.
  74. A.D. Gujar, S. Le, D.D. Mao, D.Y.A. Dadey, A. Turski, Y. Sasaki, D. Aum, J. Luo, S. Dahiya, L. Yuan, K. Rich, J. Milbrandt, D.E. Hallahan, H. Yano, D.D. Tran, A.H. Kim. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. PNAS, 2016. 113(51): p. E8247–E8256. 

Book Chapters

  1. G.A. Kerchner*, A.H. Kim*, and D.W. Choi. Glutamate-mediated excitotoxicity. In: P. Jonas and H. Monyer (eds) Ionotropic glutamate receptors in the CNS. Handbook of Exp Pharm Series. Springer Berlin Heidelberg New York, pp. 443-469. 1999. *contributed equally.
  2. A.H. Kim*, G.A. Kerchner*, and D.W. Choi. Blocking excitotoxicity. In: F.W. Marcoux and D.W. Choi (eds) CNS Neuroprotection. Handbook of Exp Pharm Series. Springer Berlin Heidelberg New York, pp. 3-36. 2002. *contributed equally.
  3. A.H. Kim and M.V. Chao. Neurotrophin signaling in development. In: R.A. Bradshaw and E.A. Dennis (eds) Handbook of Cell Signalling. Vol. 2. Elsevier: Academic Press. 2003.
  4. I.F. Dunn, A.H. Kim, and W.B. Gormley. Traumatic brain injury. In: L. Squire et al (eds) The New Encyclopedia of Neuroscience. Elsevier, 2008.
  5. A.H. Kim, M.R. Brooks, I.F. Dunn, S.F. Shaikh, and W.B. Gormley. Traumatic brain injury. In: S. Segal et al (eds) Essential Clinical Anesthesia. Cambridge University Press. 1016-1023. 2011.
  6. A.H. Kim, L.S. Governale, D.H. Kim, and P.M. Black. The management of skull base tumors. Handb Clin Neurol. 105:657-64, 2012.